Boland Lab Team
We are a team of translational scientists learning about cancer by studying patient-derived tumors and blood samples.
Principal Investigator:
Genevieve Boland, MD, PhD
Genevieve M. Boland, MD, PhD, FACS is an Associate Professor at Harvard Medical School, Vice Chair of Research at the Department of Surgery and Director of the Melanoma Surgery Program at the Massachusetts General Hospital. Her primary clinical focus is on melanoma and cutaneous oncology. She undertook combined MD/PhD training, completing a PhD in Cell and Tissue Engineering at the National Institutes of Health focusing on signaling pathways in adult, human mesenchymal stem cells.
She graduated cum laude from Thomas Jefferson University as a member of the Alpha Omega Alpha medical honor society and completed her general surgical training at Massachusetts General Hospital. Following this, she completed a clinical fellowship in Complex General Surgical Oncology and a combined research fellowship at the University of Texas MD Anderson Cancer Center. She joined the MGH Division of Surgical Oncology and is focused on the clinical management of melanoma patients. She is board certified in General Surgery and Complex General Surgical Oncology, and she is a Fellow of the American College of Surgeons.
Tatyana Sharova, MD
Tatyana Sharova is a senior clinical research coordinator in the Boland Lab. She completed her Doctoral Degree in Oncology Hematology in Pediatrics in 1999. She has 15 years of intensive basic research at Boston University Department of Dermatology with a main focus on molecular and cell biology of skin and hair. Her technical skills including expertise in biochemical analysis of RNA and DNA, DNA cloning, protein handling, multi-color IHC and IF staining methods. For the last 10 years her work was primarily focused on skin derived cells, stem cells, and induced pluripotent stem cells. She is also a former lecturer for the unique International Graduate Program in Dermatology at BU. The combination of clinical and basic science knowledge was a good start to her career in clinical research, and she completed Clinical Research Coordinator Training and HIPAA Advanced Training. She also has expertise in FDA, GCP, HIPAA, and IRB regulations and guidelines.
William Michaud, PhD
William (Bill) Michaud is a research scientist in the Boland Lab. He obtained a PhD in Biology from the University of Maryland in 2001.
He worked in the Rocco Lab from 2001 – 2014 studying molecular changes in head and neck tumors, focusing on predictors of responsiveness to therapy. He joined the Boland Lab in 2014 and has optimized techniques for exosome extraction from cell culture and human sera, RNA preparation and analysis.
In additional to his technical expertise, Bill is a talented chef, brewmaster, biker and fisherman.
Aleigha Lawless
Research Manager
Aikaterini Dedeilia, MD
Postdoctoral Research Fellow
Amina Fu
Research Technician
Madak Basnet
Research Technician
David Li
Research Technician
Emma Specht
Research Technician
TJ Otten
Clinical Research Coordinator
Derek Effiom, MD
Postdoctoral Research Fellow
Xue (Catherine) Bai, MD
Dr. Bai received a Bachelor of Clinical Medicine from Zhejiang University and Doctor of Clinical Medicine from Peking University. She has been trained in medical oncology at both Peking University Cancer Hospital/Peking University Health Science Center and Massachusetts General Hospital/Harvard Medical School. Her research focus has been on both adverse effect and efficacy of immunotherapy in advanced melanoma, particularly, the adverse effect landscapes, the impact of glucocorticoids, radiological response dynamics, and resistance to anti-PD-1 monotherapy, and the pertinent underlying mechanisms, with a specific interest in between-melanoma subtype and between-ethnicity discrepancies. Dr. Bai is the recipient of both 2020 ASCO Annual Meeting Merit Award and 2020 SITC Annual Meeting Young Investigator Award.